Suchergebnisse - "Sarilumab"

PubPharm (130)

101

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

in: Arthritis Research & Therapy | 2020

von Cem Gabay | Gerd R. Burmester | Vibeke Strand | +8

102

Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab

enthalten in: Pharmacological research | 2019

von Atzeni, F. | Nucera, V. | Masala, I. | +2

103

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

104

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

105

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

106

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

107

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate : results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis research & therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

ErratumIn: Arthritis Res Ther. 2019 Apr 16;21(1):99. - PMID 30992058

108

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

109

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

enthalten in: Arthritis Research & Therapy | 2019

von Tanaka, Y. | Wada, K. | Takahashi, Y. | +4

110

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

in: Arthritis Research & Therapy | 2019

von Yoshiya Tanaka | Kazuteru Wada | Yoshinori Takahashi | +4

[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[13]